Affiliation:
1. State Key Laboratory of New Drug and Pharmaceutical Process, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
2. Shanghai Xinshengyuan Pharmaceutical Co., Ltd., Shanghai, People's Republic of China
Abstract
AbstractsA new sanggenon-type flavanone, nigragenon F (1), together with 11 known compounds, trans-resveratrol (2), (E)-4-isopentenyl-3,5,2′,4′-tetrahydroxystilbene (3), notabilisin E (4), notabilisin A (5), morusin (6), petalopurpurenol (7), 8-geranyl-5,7-dihydroxycoumarin (8), 2,4-dihydroxybenzaldehyde (9), 4-ethoxy-2,6-dihydroxybenzoic acid (10), 3-hydroxy-4-methoxybenzaldehyde (11), and 4-hydroxybenzaldehyde (12), were isolated from the stems of Morus nigra. Compound 10 was a new natural product, compounds 3, 4, 7, and 8 were reported from the Morus genus for the first time. All of the isolated compounds were evaluated for their α-glucosidase inhibition activity. Among them, six compounds showed obvious inhibitory effects against α-glucosidase with IC50 values ranging from 1.24 to 19.00 µmol/L.
Funder
Natural Science Foundation of Shanghai
National Natural Science Foundation of China
National Science and Technology Major Project
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference20 articles.
1. Research and development progress on the synthesized utilization of mulberry;Y Li;North Sericulture,2009
2. The advancement of lowering blood glucose studies on mulberry pharmaceutical resources;N Z Jiang;Jiangsu Sericulture,2005
3. The medicinal value of Xinjiang black mulberry and its application in Uighur medicine;H Lu;Can Ye Ke Xue,2011
4. Isoprenylated flavonoids and adipogenesis-promoting constituents from Morus nigra;X Hu;J Nat Prod,2011